Adjuvant endocrine therapy for hormone receptor-positive, HER2-negative breast cancer: risk stratification, treatment intensification, and clinical management
The review summarizes current approaches to adjuvant endocrine therapy for hormone receptor-positive, HER2-negative early breast cancer. It discusses clinicopathological and biological recurrence-risk factors, assessment of endocrine sensitivity, and criteria for treatment intensification. Evidence on extended endocrine therapy, ovarian suppression, aromatase inhibitors, and the addition of CDK4/6 inhibitors is presented. Particular attention is paid to prevention of bone loss, management of adverse events, drug-drug interactions, lifestyle modification, and treatment adherence. Individual treatment selection should account for the expected absolute benefit, toxicity, comorbidities, menopausal status, and patient preferences. Adjuvant endocrine therapy is viewed as a dynamic clinical management process that requires regular assessment of efficacy and safety, prevention of complications, and timely treatment modification.
Authors
- В. Н. Дмитриев (ORCID: https://orcid.org/0000-0002-5523-5718)
- Пеганова Екатерина Вячеславовна (ORCID: https://orcid.org/0009-0009-1644-5278)
- Владислав Владимирович Петкау (ORCID: https://orcid.org/0000-0002-0342-4007)
- Гармарник Татьяна Валерьевна (ORCID: https://orcid.org/0009-0003-1865-4248)
- Константин Викторович Меньшиков (ORCID: https://orcid.org/0000-0003-3734-2779)
- Елена Владимировна Артамонова (ORCID: https://orcid.org/0000-0001-7728-9533)
- Ирина Альбертовна Королева (ORCID: https://orcid.org/0000-0002-1836-0851)
- М. В. Шомова (ORCID: https://orcid.org/0000-0002-6235-0925)
- O. A. Maslova
- R. P. Litvinov (ORCID: https://orcid.org/0009-0009-5896-4455)
- O. A. Gladkov (ORCID: https://orcid.org/0000-0003-1367-2079)
- Elena N. Vorobeva (ORCID: https://orcid.org/0000-0003-2317-9691)
- Антон Беленков (ORCID: https://orcid.org/0009-0002-3572-6613)
- D. E. Neznamov
- O. A. Agrishev
Institutions
- Pirogov Russian National Research Medical University (RU)
- Russian Cancer Research Center NN Blokhin (RU)
- Nizhny Novgorod Regional Clinical Oncology Center (RU)
- Samara Medical Institute Reaviz (RU)
- Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky (RU)
- Ministry of Health of the Russian Federation (RU)
- Medical Radiological Research Center (RU)
- Guz "Tul'skiy Oblastnoy Onkologicheskiy Dispanser (RU)
- Regional Clinical Research (US)
- Chelyabinsk Regional Clinical Oncology Center (RU)
Publication Details
- Journal
- Medical alphabet
- Published
- 2026-11-17
- DOI
- https://doi.org/10.33667/2078-5631-2026-27-22-28
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00